Le Lézard
Classified in: Health, Covid-19 virus
Subjects: PDT, TRI, MAT

KALY Evaluates Patented Cannabis Extract for Potential Coronavirus Treatment


DALLAS, March 2, 2020 /PRNewswire/ -- Kali-Extracts, Inc. (Kali, Inc. dba/Kali-Extracts, Inc.) (USOTC: KALY) ("KALY") today again confirmed efforts to evaluate its proprietary CBD extract formulation as a treatment for coronavirus symptoms. KALY's proprietary CBD formulation has been developed for the treatment of symptoms associated with Chronic Obstructive Pulmonary Disease (COPD) and other similar respiratory conditions. The formulation for the treatment of symptoms associated with COPD and other similar respiratory conditions has been derived from the company's U.S. Patented Cannabis Extraction Process. As detailed in a recently published research study (Journal of Cannabis Research) the KALY U.S. Patented CBD extract provides significant anti-inflammatory responses in vitro.  The next phase of research is now moving forward in preclinical in vivo research to expand evaluation of the effects on lung function, total body distribution, whole body clearance of the extract and dosage evaluations for maximal efficacy. KALY has filed a new patent application specifically on its CBD formulation for symptoms associated with COPD and other similar respiratory conditions. KALY has also filed for a trademark on the name RespRx as the brand name for its CBD formulation to treat the symptoms associated with COPD and other similar respiratory conditions that result from respiratory inflammation.

To learn more about RespRx, visit https://www.resprx.com/

Follow further developments at

https://www.kali-extracts.com/

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), and as such, may involve risks and uncertainties. These forward looking statements relate to, amongst other things, current expectation of the business environment in which the company operates, potential future performance, projections of future performance and the perceived opportunities in the market. The company's actual performance, results and achievements may differ materially from the expressed or implied in such forward-looking statements as a result of a wide range of factors.

CONTACT:
Frederick Ferri
ir@kali-extracts.com
+1 (214) 210-0459

SOURCE Kali-Extracts, Inc.


These press releases may also interest you

at 00:35
The digital publishing market is expected to grow by USD 64.83 billion and progress at a CAGR of almost 12% during 2020-2024. According to Technavio, the market is expected to have a neutral impact due to the spread of the COVID-19 pandemic. However,...

at 00:30
Bill.com Holdings, Inc. ("Bill.com") today announced that it has priced $1.0 billion aggregate principal amount of 0% convertible senior notes due 2025 (the "notes"). The size of the offering was increased from the previously announced $750.0...

at 00:30
The Government of Bahrain has announced the nomination of Her Excellency...

at 00:20
SpendEdge forecast the global Corporate Meeting Cards market is expected to grow by USD 46 billion as we reach 2024. This is due to the impact of the COVID-19 pandemic in the first half of 2020. However, healthy growth is expected to continue...

at 00:05
The telehealth market is poised to grow by USD 95.72 bn during 2020-2024, progressing at a CAGR of over 25% during the forecast period. Worried about the impact of COVID-19 on your Business? Here is an Exclusive report talking about Market...

at 00:00
Globally deaths from terrorism fell for the fifth consecutive year in 2019 to 13,826, a 15 per cent decrease from the prior year In North America, Western Europe and Oceania, far-right attacks have increased by 250 per cent since 2014 - they are...



News published on 2 march 2020 at 10:00 and distributed by: